Impact of the BOOST GAIT Program on Gait Recovery and Functional Mobility After Stroke
Launched by HASSELT UNIVERSITY · Sep 21, 2024
Trial Information
Current as of August 21, 2025
Recruiting
Keywords
ClinConnect Summary
The BOOST GAIT trial is studying whether a special therapy program can help improve walking and daily activities for patients who have had a stroke and still have some ability to walk. The program includes extra therapy sessions over four weeks, where small groups of patients work with physiotherapists on exercises that focus on standing, stepping, and walking. The goal is to help patients regain a more normal walking pattern, which may make it easier for them to move around safely in their everyday lives.
To participate in this study, you need to be at least 18 years old and have had a first-time stroke within the last three months. You should also be receiving rehabilitation at Jessa hospital in Herk-de-Stad and have some basic balance and mobility skills. During the trial, you'll receive additional therapy on top of your usual care, and the researchers will track your progress using special sensors to see how well you’re moving. This study is still recruiting participants, and while it involves a small group for now, the information gathered will help plan a larger study in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • A first-ever unilateral stroke, infarction or bleeding
- • Undergoing inpatient rehabilitation in the Jessa hospital, Herk-de-Stad
- • Less than 3 months after stroke onset at the moment of inclusion
- • 18 years of older
- • Berg Balance Scale score 24 or higher (out of 56) at moment of inclusion
- • Timed Up-and-Go score 14 s or higher at moment of inclusion
- • Functional Ambulation Category 3 or higher at moment of inclusion
- • Understanding the goals and procedures of this study and giving informed consent
- Exclusion Criteria:
- • Significant cognitive and/or speech impairments that markedly affect the comprehension and execution of instructions
About Hasselt University
Hasselt University is a prestigious research institution located in Belgium, renowned for its commitment to advancing scientific knowledge and innovation. With a strong focus on interdisciplinary research, the university actively engages in clinical trials that aim to address pressing health challenges. Leveraging a robust network of collaborations with healthcare professionals, industry partners, and research organizations, Hasselt University strives to translate research findings into practical applications that benefit patient care and public health. The institution is dedicated to maintaining the highest ethical standards and regulatory compliance in all its clinical research endeavors.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Herk De Stad, Limburg, Belgium
Patients applied
Trial Officials
Peter Feys, Professor
Principal Investigator
Hasselt University, REVAL Rehabilitation Research center
Maaiken Vander Plaetse, MD
Principal Investigator
FRAME, Jessa Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported